Publications
- Induction of tolerance and immunity by dendritic cells: Mechanisms and clinical applications2019 | Second Faculty of Medicine
- Relevance of the chaperone-like protein calreticulin for the biological behavior and clinical outcome of cancer2018 | Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy2018 | Second Faculty of Medicine
- Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors2018 | Second Faculty of Medicine
- Chapter Three - Rationale for the Combination of Dendritic Cell-Based Vaccination Approaches With Chemotherapy Agents2017 | Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients2016 | First Faculty of Medicine, Second Faculty of Medicine
- Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis2016 | Second Faculty of Medicine
- Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy2016 | Second Faculty of Medicine
- Trial Watch: Immunotherapy plus radiation therapy for oncological indications2016 | Second Faculty of Medicine
- Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer2015 | Second Faculty of Medicine
Loading network view...
